31150730|t|The role of APOE in transgenic mouse models of AD.
31150730|a|Identified in 1993, APOE4 is the greatest genetic risk factor for Alzheimer's disease (AD), increasing risk up to 15-fold compared to the common variant APOE3. Since the mid 1990's, transgenic (Tg) mice have been developed to model AD pathology and progression, primarily via expression of the familial AD (FAD) mutations in the presence of mouse-APOE (m-APOE). APOE4, associated with enhanced amyloid-beta (Abeta) accumulation, has rarely been the focus in designing FAD-Tg mouse models. Initially, FAD-Tg mice were crossed with human (h)-APOE driven by heterologous promoters to identify an APOE genotype-specific AD phenotype. These models were later supplemented with FAD-Tg mice crossed with APOE-knockouts (APOE-/- or APOE-KO) and h-APOE-targeted replacement (h-APOE-TR) mice, originally generated to study the role of APOE genotype in peripheral lipid metabolism and atherosclerotic lesion development. Herein, we compare the m- and h-APOE multi-gene clusters, and then critically review the relevant history and approaches to developing a Tg mouse model to characterize APOE-dependent AD pathology, in combination with genetic (sex, age) and modifiable (e.g., inflammation, obesity) risk factors. Finally, we present recent data from the EFAD mice, which express 5xFAD mutations with the expression of the human apoE isoforms (E2FAD, E3FAD and E4FAD). This includes a study of 6- and 18-month-old male and female E3FAD and E4FAD, a comparison that enables examination of the interaction among the main AD risk factors: age, APOE genotype and sex. While no single transgenic mouse can capture the effects of all modifiable and genetic risk factors, going forward, a conscious effort needs to be made to include the factors that most significantly modulate AD pathology.
31150730	12	16	APOE	Gene	348
31150730	31	36	mouse	Species	10090
31150730	47	49	AD	Disease	MESH:D000544
31150730	117	136	Alzheimer's disease	Disease	MESH:D000544
31150730	138	140	AD	Disease	MESH:D000544
31150730	249	253	mice	Species	10090
31150730	283	285	AD	Disease	MESH:D000544
31150730	345	356	familial AD	Disease	MESH:D000544
31150730	358	361	FAD	Disease	MESH:D000544
31150730	392	397	mouse	Species	10090
31150730	398	402	APOE	Gene	348
31150730	406	410	APOE	Gene	348
31150730	459	464	Abeta	Gene	11820
31150730	519	522	FAD	Disease	MESH:D000544
31150730	526	531	mouse	Species	10090
31150730	551	554	FAD	Disease	MESH:D000544
31150730	558	562	mice	Species	10090
31150730	581	586	human	Species	9606
31150730	591	595	APOE	Gene	348
31150730	644	648	APOE	Gene	348
31150730	667	669	AD	Disease	MESH:D000544
31150730	723	726	FAD	Disease	MESH:D000544
31150730	730	734	mice	Species	10090
31150730	748	752	APOE	Gene	348
31150730	764	768	APOE	Gene	348
31150730	775	779	APOE	Gene	348
31150730	790	794	APOE	Gene	348
31150730	819	823	APOE	Gene	348
31150730	828	832	mice	Species	10090
31150730	876	880	APOE	Gene	348
31150730	904	909	lipid	Chemical	MESH:D008055
31150730	925	947	atherosclerotic lesion	Disease	MESH:D050197
31150730	993	997	APOE	Gene	348
31150730	1101	1106	mouse	Species	10090
31150730	1129	1133	APOE	Gene	348
31150730	1144	1146	AD	Disease	MESH:D000544
31150730	1219	1231	inflammation	Disease	MESH:D007249
31150730	1233	1240	obesity	Disease	MESH:D009765
31150730	1302	1306	mice	Species	10090
31150730	1365	1370	human	Species	9606
31150730	1371	1375	apoE	Gene	348
31150730	1472	1477	E3FAD	Disease	
31150730	1482	1487	E4FAD	Disease	
31150730	1561	1563	AD	Disease	MESH:D000544
31150730	1583	1587	APOE	Gene	348
31150730	1633	1638	mouse	Species	10090
31150730	1814	1816	AD	Disease	MESH:D000544
31150730	Association	MESH:D008055	348
31150730	Association	MESH:D000544	348
31150730	Association	MESH:D050197	348

